GV 2019, L.P.
CIK 1845041 · last filed 2026-07-29
GV 2019, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LIFE, was dated Jul 29, 2026. Across all open-market trades the lifetime net is +$46.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.43M
3
6
$46.55M
Holdings By Company
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-29 | LIFE | Mixed | −4,410,966 | -$42.46M | EDGAR |
| 2023-06-13 | PRME | Mixed | −443,842 | -$3.27M | EDGAR |
| 2023-05-26 | PRME | Mixed | −434,854 | -$2.93M | EDGAR |
| 2023-05-08 | PRME | Notice (144) | −1,121,197 | -$16.06M | EDGAR |
| 2022-10-26 | PRME | Mixed | +92,992,816 | $95.20M | EDGAR |
| 2021-02-17 | Decibel Therapeutics, Inc. (DBTX) Delisted | Conv (C) | +2,458,893 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.